Financial Performance - The company's revenue for Q3 2022 was CNY 282,217,000, a decrease of 46.27% compared to the same period last year[4]. - Net profit attributable to shareholders for Q3 2022 reached CNY 40,498,525, representing a significant increase of 191.69% year-on-year[4]. - Total operating revenue for Q3 2022 was CNY 704,172,551.97, a decrease of 24.3% compared to CNY 930,748,830.50 in Q3 2021[32]. - The net profit for Q3 2022 was a loss of CNY 42,475,513.77, compared to a profit of CNY 984,176.03 in Q3 2021, indicating a significant decline[33]. - The total comprehensive income for the third quarter was -42,475,513.77 CNY, with the parent company's comprehensive income at -39,979,184.95 CNY[34]. Cash Flow - The net cash flow from operating activities for the year-to-date period was CNY 120,835,185, down 56.40% compared to the previous year[4]. - Cash flow from operating activities improved by 56.40% to CNY -12,083.52 million, due to increased sales collections and reduced employee wages and taxes[13]. - The net cash flow from operating activities was -120,835,185.11 CNY, an improvement from -277,162,184.18 CNY in the previous period[37]. - Cash inflow from operating activities totaled 927,614,788.48 CNY, compared to 789,102,835.01 CNY in the prior year[37]. - The net cash flow from financing activities was 510,860,242.56 CNY, compared to 445,900,695.80 CNY in the previous period[38]. Assets and Liabilities - Total assets as of September 30, 2022, were CNY 3,522,288,028.13, reflecting a growth of 6.73% from the end of the previous year[5]. - The company's total assets increased to CNY 3,522,288,028.13 in Q3 2022 from CNY 3,300,319,525.95 in Q3 2021, representing a growth of 6.7%[28]. - Current liabilities decreased to CNY 857,718,629.79 in Q3 2022 from CNY 1,154,226,799.52 in Q3 2021, a reduction of 25.7%[29]. - The total liabilities increased to CNY 1,878,951,553.86 in Q3 2022 from CNY 1,615,259,894.10 in Q3 2021, marking a rise of 16.3%[29]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 37,903, with no preferred shareholders[15]. - The largest shareholder, Liu Zhaogui, holds 22.56% of shares, totaling 112,116,306 shares[15]. Borrowings and Interest - The company’s long-term borrowings increased by 129.22% to CNY 99,282,420, primarily due to new borrowings related to PPP projects[10]. - Interest expenses rose by 103.92% to CNY 1,757.47 million, attributed to reduced capitalization of bank loan interest for the Ya'an and Anyue PPP projects and increased bank borrowings[12]. - The company received 826,374,764.96 CNY in borrowings during the period, up from 715,562,266.13 CNY in the previous year[38]. Investments and Income - Investment income surged by 703.18% to CNY 353.53 million, driven by increased investment returns from associated companies[12]. - Non-operating income for the year-to-date period totaled CNY 1,167,020.42, down from CNY 2,368,774.67 in the previous year[7]. - The total cash inflow from investment activities was 105,647,951.82 CNY, down from 265,375,131.59 CNY in the previous year[37]. Operational Efficiency - The company reported a significant increase in credit impairment losses by 110.62% to CNY -1,999.78 million, due to higher provisions for bad debts[12]. - The company confirmed an increase in contract assets by 33.42% to CNY 86,705,400, attributed to the recognition of income from PPP projects[10]. - The company reported a significant increase in cash flow, indicating improved liquidity and operational efficiency[26]. Strategic Initiatives - The company is focusing on expanding its market presence through strategic acquisitions and partnerships in the environmental technology sector[22]. - The company plans to enhance its research and development efforts in energy conservation technologies and environmental protection equipment[22]. - The company is committed to sustainable practices and aims to leverage its technological advancements in the environmental sector[22]. - The company’s management indicated a positive outlook for the upcoming quarters, driven by increased demand for environmental services and products[22]. Changes in Subsidiaries - The company established a wholly-owned subsidiary, Jiangsu Guoce Environmental Testing Co., Ltd., with a registered capital of CNY 10 million, focusing on inspection and testing services[24]. - The company’s subsidiary, Sichuan Tianrui Environmental Technology Co., Ltd., changed its name to Sichuan Tianrui Energy Conservation and Environmental Protection Technology Co., Ltd., expanding its business scope to include environmental protection equipment manufacturing and energy management services[21]. - The company’s subsidiary, Shanghai Panhe Scientific Instrument Co., Ltd., expanded its business scope to include sales of intelligent instruments and environmental monitoring instruments[23].

证券代码： 300165 证券简称：天瑞仪器 江苏天瑞仪器股份有限公司投资者关系活动记录表 | --- | --- | |----------------|--------------------------------------| | 投资者关系活动 | □ 特定对象调研 | | 类别 | □ 媒体采访 √ | | | □ 新闻发布会 □ | | | □ 现场参观 | | | □ 其他 | | 参与单位名称及 | | | 人员姓名 | 绩说明会的投资者 | | 时间 | 2023 年 5 月 10 | | 地点 | 公司通过全景网"投资者关系互动平台"（ | | | 采用网络远程的方式召开业绩说明会 | | 上市公司接待人 | 1、董事长刘召贵 | | 员姓名 | 2、董事会秘书朱蓉 | | | 3、财务总监吴志进 | | | 4、独立董事莫卫民 | | | 5、保荐代表人许寅 | | | | | | 司于 2023 年 5 月 10 | | | 关系互动平台"举办 | | | | | | 题进行了回复。主要问题和回复如下： | | 投资者关系活动 | | | 主要内容介绍 | 1 | | | | | | ...

Financial Performance - The net profit attributable to shareholders of the listed company for 2022 was -103.68 million yuan, a year-on-year decrease of 90.94%[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -109.52 million yuan, a year-on-year decrease of 59.45%[5]. - The decline in performance was primarily due to significant goodwill impairment and increased credit impairment losses from subsidiaries[5]. - The company's operating revenue for 2022 was ¥1,289,631,015.62, a decrease of 16.39% compared to ¥1,542,429,056.82 in 2021[27]. - The net profit attributable to shareholders was -¥103,675,199.03, representing a decline of 90.94% from ¥21,105,083.14 in 2021[27]. - The cash flow from operating activities was -¥411,982,505.66, an improvement of 18.23% from -¥503,828,082.07 in 2021[27]. - The weighted average return on equity was -6.55%, a decline of 100.92% from the previous year[32]. - The net assets attributable to shareholders decreased by 7.41% to CNY 1,511,915,045.49 at the end of 2022[32]. - The cash flow from operating activities was negative at CNY -291,147,320.55 for the year[35]. - The company faced uncertainty regarding its ability to continue as a going concern, as indicated in the audit report[32]. Research and Development - The company plans to continue increasing R&D investment to enhance technological innovation and improve industry position and sustainable development capabilities[5]. - The company has invested significantly in R&D, maintaining its leadership position in the domestic analysis instrument industry for the foreseeable future[72]. - The company has a strong focus on independent innovation, with 122 non-patent technologies developed through R&D efforts[73]. - The company has allocated 200 million yuan for research and development in 2023, focusing on innovative analytical solutions[78]. - The company is investing in research and development for new products, particularly in the field of environmental monitoring and analysis[189]. Market Expansion and Strategy - Future strategies include market expansion and potential mergers and acquisitions to enhance growth prospects[25]. - The company is exploring strategic partnerships and potential acquisitions to enhance its product offerings and market reach[75]. - Jiangsu Tianrui plans to enter new markets in Southeast Asia, targeting a market share increase of 5% within the next two years[77]. - The company is expanding its market presence in Southeast Asia, targeting a 30% increase in sales in this region by 2024[84]. - The company is actively pursuing mergers and acquisitions to strengthen its position in the environmental protection industry[186]. Environmental and Technological Focus - The company is actively exploring business in ecological protection and environmental governance, but faces operational risks due to the large investment and long cooperation periods associated with PPP projects[11]. - The environmental protection industry, which the company is involved in, is supported by national policies and is expected to grow with increasing public awareness and demand for sustainable practices[45]. - The company has established a leading market position in the industrial testing sector, focusing on high-end analytical instruments such as spectrometers and mass spectrometers[49]. - The company is focusing on the development of environmental monitoring and laboratory analysis instruments, which are critical for various industries[44]. - The company is committed to sustainability, with initiatives aimed at reducing its carbon footprint by 30% over the next five years[103]. Operational Challenges - The company’s accounts receivable balance is large, leading to pressure on cash flow and financial stability[16]. - The company reported a significant asset impairment loss of -107.38 million yuan, primarily due to goodwill impairment[148]. - The overall performance in 2022 indicates a need for improved operational efficiency and cost management to mitigate losses in certain divisions[188]. - The company has reported a loss of ¥4.99 million in its environmental science division, indicating challenges in this segment[188]. Product Development and Innovation - The company has developed a comprehensive product line in the analytical instrument sector, including high-end instruments like spectrometers and mass spectrometers, with applications in environmental protection, consumer safety, and industrial testing[62]. - New product developments include the launch of a portable volatile organic compound analyzer and a high-precision Raman spectrometer, expected to enhance market competitiveness[82]. - The company has established a robust pipeline of new products, with several patents pending for advanced analytical technologies[76]. - The company has successfully launched three new products in the last quarter, including advanced spectrometers, which are expected to enhance competitive advantage in the market[79]. Financial Health and Investments - The company has a total of 12 wholly-owned subsidiaries and several equity investees, indicating a diversified operational structure[25]. - The company has recognized goodwill impairment based on the actual operating conditions of acquired enterprises, which may impact future profits[9]. - The company has received support from industrial policies, benefiting from the transformation and upgrading of the manufacturing sector[71]. - The company has reported a significant increase in its patent portfolio, with over 70 patents authorized since 2012, enhancing its competitive edge in the market[76]. User Engagement and Market Demand - The company has expanded its user base, with over 50,000 active users of its analytical instruments, marking a 20% increase compared to the previous year[78]. - User data indicates that the number of active users of the company's products has grown by 25% year-on-year, reaching 1.5 million users[84]. - The company has expanded its user base, with active users increasing by 20% to reach 500,000 in 2022[81]. - User data indicates a growing customer base, with an increase of 20% in active users compared to the previous year, reaching 500,000 active users[86].

Financial Performance - The company reported a net profit attributable to shareholders of -54.2964 million yuan in 2021, a significant decline of 357.27% year-on-year, primarily due to substantial goodwill impairment and increased operating expenses [6]. - The company's operating revenue for 2021 was ¥1,542,429,056.82, representing a 64.84% increase compared to ¥935,696,717.93 in 2020 [25]. - The net profit attributable to shareholders was -¥54,296,434.85 in 2021, a decrease of 357.27% from ¥21,105,083.14 in 2020 [25]. - The net cash flow from operating activities was -¥503,828,082.07, down 462.83% from ¥138,859,567.05 in 2020 [25]. - The company reported a basic earnings per share of -¥0.11 for 2021, a decline of 320.00% from ¥0.05 in 2020 [25]. - The profit distribution plan for 2021 includes no cash dividends or bonus shares, with no capital reserve conversion to shares [10]. - The company reported a net profit excluding non-recurring items of CNY -68.68 million, down 90.34% year-on-year [110]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion RMB, representing a year-over-year growth of 20% [71]. - The company reported a significant increase in revenue, achieving a total of 2,917,410,000 CNY for the year 2021 [92]. Market Position and Strategy - The company plans to continue enhancing its industry position, competitive capabilities, and sustainable development to improve operational performance [6]. - The company aims to transition from a single analysis instrument supplier to a comprehensive service provider in analysis detection through acquisitions and product diversification [58]. - The company is exploring potential mergers and acquisitions to enhance its market position and expand its product offerings [74]. - The company is focusing on expanding its market presence through strategic partnerships and collaborations, particularly in the biomedical sector [82]. - The company is committed to enhancing its technical consulting services in the medical and environmental sectors [145]. - The company is focusing on the development and sales of environmental monitoring instruments, which is a key area of growth [145]. - The company is actively involved in the research and development of medical equipment and environmental monitoring technologies [145]. Research and Development - The company has invested significantly in R&D and product line expansion, maintaining its leadership position in the domestic analysis instrument sector [69]. - The company has invested 100 million RMB in R&D for new technologies, focusing on advanced spectrometry solutions [71]. - Research and development expenses accounted for 8% of total revenue, reflecting the company's commitment to innovation [75]. - The company is investing heavily in R&D, with a budget allocation of 200 million yuan for the development of new technologies and products in the upcoming year [74]. - The company has developed multiple new products, including various X-ray fluorescence analysis systems and software [87]. - The company has focused on enhancing its technological capabilities, with multiple software releases aimed at improving air quality monitoring and analysis [93]. Subsidiaries and Acquisitions - The company's subsidiary, Tianrui Environment, has extensive experience in environmental protection, providing services such as industrial wastewater and air treatment engineering, and has formed a closed-loop service system from monitoring to remediation [44]. - The company’s subsidiary, Bexi Bio, focuses on POCT cardiovascular testing products, enhancing its competitiveness through increased R&D investment and expanding its product range [45]. - The company has successfully completed two acquisitions in the past year, enhancing its product portfolio and market reach [91]. - The company acquired 51% of Jiangsu Guoce Testing Technology Co., Ltd. using over-raised funds amounting to 43.71 million RMB, completed on December 22, 2016 [169]. - The company purchased 55.42% of Shanghai Panhua Scientific Instrument Co., Ltd. for 168.82 million RMB, with the acquisition completed on July 27, 2017 [170]. Risks and Challenges - The company faces risks from intensified market competition, particularly from international firms like Thermo Fisher and Shimadzu, which may lead to reduced market share and lower gross margins [8]. - The company has faced uncertainty regarding its ability to continue as a going concern, as indicated by the audit report [25]. - The company faces market competition risks from international giants and low-end product homogenization, which affects overall industry profitability [186]. - There is a risk of goodwill impairment from acquired companies if their future operating conditions deteriorate, potentially reducing current profits [188]. - The company faces risks related to talent and technology loss, which could negatively impact operations if key personnel leave or if there is a leak of technical secrets [187]. Environmental and Regulatory Factors - The company is actively exploring business opportunities in ecological protection and environmental governance, but the PPP model poses operational risks due to high investment and long cooperation periods [9]. - The implementation of the revised "Science and Technology Progress Law" in December 2021 aims to protect the market position of domestic instruments, promoting their development [47]. - The government’s "14th Five-Year Plan" emphasizes the importance of environmental quality improvement, which is expected to accelerate market demand for environmental monitoring instruments [52]. - The company is committed to sustainability, with initiatives aimed at reducing carbon emissions by 30% over the next five years [81]. Product Development and Innovation - The company has developed a comprehensive procurement system, including negotiation, competitive procurement, and inquiry-based procurement methods to ensure material quality [65]. - The company has launched new products, including a gas chromatography mass spectrometer (GC-MS 6800S) and a high-precision gear transmission automatic switching device [78]. - New product development includes the launch of a high-resolution semiconductor radiation detector, which is expected to enhance market competitiveness [72]. - The introduction of new products such as the fully automatic drug residue detection instrument and pesticide residue detection instrument is expected to drive future growth [82]. - The company has successfully obtained multiple patents, including a new coronavirus testing reagent card and a mobile emergency nucleic acid testing vehicle, enhancing its product portfolio [82]. Financial Management and Investments - The company has established a governance structure that complies with relevant laws and regulations, ensuring effective decision-making and protection of shareholder rights [192]. - The company reported a total investment of 18,000,000,000 with a 100% ownership stake [143]. - The company has not encountered significant changes in the feasibility of its projects, ensuring ongoing alignment with strategic goals [154]. - The company has effectively utilized existing technical platforms to reduce costs in the headquarters service management center upgrade project [156]. - The company has not sold any significant assets or equity during the reporting period [160][161].

Financial Performance - The company's revenue for Q1 2023 was ¥150,599,832.55, a decrease of 23.33% compared to ¥196,426,783.79 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥2,590,555.54, representing a decline of 127.41% from a profit of ¥9,451,237.79 in the previous year[5] - The company's basic and diluted earnings per share were both -¥0.0101, a decrease of 153.16% from ¥0.019 in the same period last year[5] - Net profit for Q1 2023 was a loss of CNY 4,980,132.24, compared to a profit of CNY 9,361,839.69 in the same period last year[24] - Total operating revenue for Q1 2023 was CNY 150,599,832.55, a decrease from CNY 196,426,783.79 in the previous period[23] - Total operating costs for Q1 2023 were CNY 155,356,912.19, down from CNY 189,185,117.31 year-over-year[23] Cash Flow - The net cash flow from operating activities was -¥80,450,899.47, a decrease of 47.72% compared to -¥54,461,417.24 in the same period last year[5] - The cash inflow from operating activities totaled ¥270,522,513.80, an increase of 2.7% compared to ¥262,802,580.34 in the previous period[28] - The company's total cash outflow for operating activities was ¥350,973,413.27, compared to ¥317,263,997.58 in the previous period, indicating a 10.6% increase[28] - The company reported a decrease in cash received from other operating activities, totaling ¥6,437,255.22, down from ¥18,833,308.21[28] - Cash outflow for purchasing goods and services was ¥217,371,294.83, up from ¥176,034,123.65, reflecting a 23.5% increase[28] - The ending balance of cash and cash equivalents was ¥368,015,352.15, up from ¥297,891,372.25 in the prior period[29] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,696,378,176.64, down 2.54% from ¥3,792,613,192.61 at the end of the previous year[5] - Current assets decreased to CNY 3,088,110,584.29 from CNY 3,189,532,183.15, reflecting a decline of approximately 3.2%[19] - Cash and cash equivalents decreased to CNY 368,015,352.15 from CNY 410,153,060.81, a reduction of about 10.3%[18] - Accounts receivable decreased to CNY 344,748,193.77 from CNY 448,441,523.37, representing a decline of approximately 23.1%[19] - The total liabilities as of March 31, 2023, were not explicitly stated but included short-term borrowings of CNY 312,360,904.32, which remained relatively stable compared to CNY 312,060,079.61 at the beginning of the year[19] - The company's total liabilities decreased to CNY 2,138,954,509.58 from CNY 2,230,448,163.42[21] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 40,475, with the largest shareholder holding 21.50% of the shares[12] - The company reported a total of 95,271,942 shares under lock-up agreements for executives, indicating a commitment to long-term stability[16] - The total equity attributable to shareholders of the parent company was CNY 1,509,563,260.06, slightly down from CNY 1,511,915,045.49[21] Investment and Development - Investment income increased by 198.67% to ¥300,712.33, primarily due to higher financial management returns[9] - The company reported a net cash outflow from investing activities of -¥69,338,720.37, an improvement of 13,340,432.35 compared to the previous year[10] - The company has a long-term investment of CNY 81,290,616.52, which increased from CNY 78,890,616.52 at the beginning of the year, reflecting a growth of approximately 3.0%[19] - The company’s development expenditure increased to CNY 9,160,842.67 from CNY 6,767,420.45, marking an increase of about 35.0%[19] - The company’s goodwill remained stable at CNY 178,692,839.97, indicating no impairment or changes during the quarter[19] Future Outlook - Future outlook includes potential strategies for market expansion and new product development, although specific details were not disclosed in the report[24]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 江苏天瑞仪器股份有限公司（以下简称"公司"）定于 2023 年 5 月 10 日（星 期三）15:00-16:30 在全景网举办 2022 年度业绩说明会，本次年度业绩说明会 将采用网络远程的方式举行，投资者可登陆全景网"投资者关系互动平台" （https://ir.p5w.net）参与本次年度业绩说明会。 证券代码：300165 证券简称：天瑞仪器 公告编号：2023－029 江苏天瑞仪器股份有限公司 关于举行 2022 年度网上业绩说明会的公告 （问题征集专题页面二维码，扫码自动匹配移动端） 特此公告。 江苏天瑞仪器股份有限公司董事会 二○二三年四月二十七日 出席本次说明会的人员有：公司董事长刘召贵先生、财务总监吴志进先生、 独立董事莫卫民先生、董事会秘书朱蓉女士、保荐代表人许寅先生。 为充分尊重投资者、提升交流的针对性，现就公司 2022 年度业绩说明会提 前向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2023 年 5 月 10 日（星期三）15：00 前访问 https://ir.p5w ...

Financial Performance - The company's revenue for Q3 2022 was ¥155,144,733.35, a decrease of 24.82% compared to the same period last year[4] - The net profit attributable to shareholders was -¥35,382,870.93, representing a decline of 229.10% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥36,549,891.35, down 129.18% from the previous year[4] - Total operating revenue for the current period was CNY 528,322,707.98, a decrease of 13.4% compared to CNY 611,846,115.79 in the previous period[29] - Net profit for the current period was CNY -66,671,622.16, a significant decline from CNY 5,064,063.70 in the previous period, with a loss attributable to shareholders of CNY -61,784,418.74[31][32] - Basic and diluted earnings per share were both CNY -0.1243, compared to CNY 0.0083 in the previous period[32] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,447,231,568.68, an increase of 6.34% compared to the end of the previous year[4] - The company's total liabilities increased to CNY 1,845,284,363.40 from CNY 1,573,968,545.44, indicating a rise in financial obligations[30] - Non-current liabilities rose significantly to CNY 1,020,913,466.12 from CNY 460,713,636.63, primarily due to an increase in long-term borrowings[30] - Shareholders' equity attributable to the parent company decreased to CNY 1,551,772,176.24 from CNY 1,612,804,238.79, reflecting a decline in retained earnings[30] - The total assets of the company reached CNY 3,447,231,568.68, compared to CNY 3,241,835,016.69 in the previous period, indicating growth in asset base[30] Cash Flow - The cash flow from operating activities showed a net outflow of -¥120,835,185.11, which is a 56.40% improvement compared to the same period last year[4] - The net cash flow from operating activities was -120,835,185.11 CNY, an improvement from -277,162,184.18 CNY in the previous year[34] - Cash inflow from operating activities totaled CNY 927,614,788.48, an increase from CNY 789,102,835.01 in the previous period[32] - The net cash flow from financing activities was ¥51,086.02 million, an increase of 14.57% year-on-year[12] - The net cash flow from financing activities was 510,860,242.56 CNY, an increase from 445,900,695.80 CNY year-over-year[34] Shareholder Information - Total number of common shareholders at the end of the reporting period is 37,903[14] - Liu Zhaogui holds 22.56% of shares, totaling 112,116,306 shares, with 87,326,306 shares under lock-up[14] - The second largest shareholder, a fund management company, holds 5.63% with 28,000,000 shares[14] - The company has a total of 87,326,306 locked shares for Liu Zhaogui, which cannot exceed 25% of his total shares during his tenure[17] - The company reported that 0 shares were released from lock-up during the current period for Liu Zhaogui and Ying Gang[17] Investment and Expenses - The company reported a significant increase in financial expenses, totaling ¥2,039.41 million, up 287.10% due to increased bank borrowings for project financing[11] - Investment income increased to ¥353.53 million, a rise of 703.18% compared to the previous year, attributed to higher returns from equity method investments[11] - The company reported a decrease in income tax expenses to ¥228.31 million, down 70.59% due to reduced profits in the reporting period[11] - Total cash inflow from investment activities was 105,647,951.82 CNY, down from 265,375,131.59 CNY year-over-year[34] - Cash outflow for investment activities totaled 392,952,470.62 CNY, compared to 509,620,687.28 CNY in the same period last year[34]

Financial Performance - The company's operating revenue for the first half of 2022 was approximately ¥373.18 million, a decrease of 7.97% compared to ¥405.48 million in the same period last year[21]. - The net profit attributable to shareholders of the listed company was a loss of approximately ¥26.40 million, a decline of 277.39% compared to a profit of ¥14.88 million in the previous year[21]. - The basic and diluted earnings per share were both -¥0.05, a decrease of 266.67% compared to ¥0.03 in the same period last year[21]. - The net profit after deducting non-recurring gains and losses was a loss of approximately ¥27.60 million, a decline of 295.14% compared to ¥14.15 million in the previous year[21]. - The total comprehensive income for the first half of 2022 was a loss of CNY 30.84 million, compared to a gain of CNY 13.72 million in the previous year[193]. - The company's operating profit turned negative at CNY -26.03 million, down from a profit of CNY 20.36 million in the previous year[192]. - The company reported a total loss of CNY 2,037,967.12 from its subsidiary in Qingshui, indicating the need for strategic adjustments in this area[96]. Cash Flow and Liquidity - The net cash flow from operating activities improved by 37.87%, amounting to a loss of approximately ¥164.66 million, compared to a loss of ¥265.03 million in the same period last year[21]. - The net cash flow from financing activities increased by 55.85%, reaching ¥438.02 million compared to ¥280.11 million in the previous year[53]. - Operating cash inflow for the first half of 2022 was CNY 556,797,594.43, an increase of 12.2% compared to CNY 496,142,165.88 in the first half of 2021[198]. - The total cash and cash equivalents at the end of the period increased to CNY 451,656,233.14 from CNY 269,467,155.97, marking a recovery in liquidity[200]. - Cash received from sales of goods and services rose to CNY 469,254,302.12, up from CNY 376,207,487.96, indicating strong revenue growth[198]. Assets and Liabilities - Total assets increased by 12.25% to approximately ¥3.64 billion, up from ¥3.24 billion at the end of the previous year[21]. - The net assets attributable to shareholders of the listed company decreased by 1.61% to approximately ¥1.59 billion from ¥1.61 billion at the end of the previous year[21]. - Long-term borrowings increased by 98.35% year-over-year to approximately ¥859.13 million, reflecting financing for ongoing projects[60]. - Total liabilities increased to CNY 2,001,327,083.17, up from CNY 1,573,968,545.44, representing a growth of approximately 27%[183]. Research and Development - Research and development investment decreased by 10.93% to ¥34.50 million from ¥38.73 million in the previous year[53]. - The company emphasizes independent innovation and has accumulated substantial technical strength in analytical instruments, aiming to maintain its leadership position in the industry[38]. - The company has established a competitive advantage in the analytical instrument market through strong R&D capabilities and a comprehensive product line[29]. Market Position and Strategy - The company is a leader in the domestic analytical instrument industry, focusing on analysis and testing, environmental monitoring, and ecological governance, with a strong emphasis on R&D capabilities[28]. - The company operates under a direct sales model as its primary sales strategy, supplemented by a distribution model for broader market reach[37]. - The company is positioned to benefit from the trend of domestic substitution in the high-end analytical instrument market, as reliance on imports decreases[38]. - The company is focusing on expanding its market presence in environmental protection equipment and services, particularly in wastewater treatment and solid waste management[96]. Subsidiaries and Acquisitions - The company has completed the acquisition of Suzhou Tianrui Environmental Technology Co., Ltd. for ¥9,725.06 million, achieving 84.09% of the expected investment[77]. - The company’s subsidiary, Tianrui Environment, has established a closed-loop service system in environmental protection, covering monitoring, diagnosis, treatment, and maintenance[46]. - The company has established a subsidiary in Hubei with an investment of 19 million CNY to focus on environmental product development and consulting[103]. Risks and Challenges - The company faces operational risks from the PPP business model due to large investment amounts and long cooperation periods, which may affect profitability[113]. - The company emphasizes the importance of innovation and aims to enhance its core competitiveness to address market competition risks[111]. - The company plans not to distribute cash dividends or issue bonus shares for the semi-annual period[119]. Shareholder Information - The company’s total share capital is 496,990,870 shares, with 77.57% being unrestricted shares[161]. - Liu Zhaogui holds 23.41% of the shares, totaling 116,326,306 shares, with 29,000,000 shares under sale conditions[167]. - The largest shareholder, Liu Zhaogui, has not changed his holdings during the reporting period[167].

Financial Performance - Revenue for Q1 2022 was CNY 196,426,783.79, a decrease of 6.20% compared to CNY 209,411,764.69 in the same period last year[3] - Net profit attributable to shareholders was CNY 9,451,237.79, down 38.42% from CNY 15,347,795.32 year-on-year[3] - Total operating revenue for Q1 2022 was CNY 196.43 million, a decrease of 6.4% compared to CNY 209.41 million in Q1 2021[20] - Net profit for Q1 2022 was CNY 9.36 million, a decline of 38.5% from CNY 15.22 million in Q1 2021[21] - Earnings per share for Q1 2022 was CNY 0.019, compared to CNY 0.0309 in Q1 2021[22] Cash Flow - Net cash flow from operating activities was negative CNY 54,461,417.24, a decline of 132.30% compared to negative CNY 23,443,996.87 in the previous year[3] - The net cash flow from operating activities was -54,461,417.24 CNY, compared to -23,443,996.87 CNY in the previous year, indicating a decline in operational performance[25] - Total cash inflow from financing activities was 111,026,521.46 CNY, down from 227,993,529.57 CNY year-over-year, reflecting reduced financing activities[26] - The total cash and cash equivalents at the end of the period were 297,891,372.25 CNY, a decrease from 438,516,403.86 CNY in the previous year[26] - The cash outflow from investing activities was 118,006,712.24 CNY, significantly lower than 257,218,608.36 CNY in the same period last year, indicating a reduction in investment expenditures[25] Assets and Liabilities - Total assets increased by 5.00% to CNY 3,404,074,535.12 from CNY 3,241,835,016.69 at the end of the previous year[3] - Total assets as of Q1 2022 amounted to CNY 3.40 billion, an increase from CNY 3.24 billion in the previous year[18] - Total liabilities reached CNY 1.73 billion in Q1 2022, up from CNY 1.57 billion in Q1 2021[18] - Long-term borrowings increased to CNY 524.33 million in Q1 2022, compared to CNY 433.14 million in the same period last year[18] Operational Costs - Total operating costs for Q1 2022 were CNY 189.19 million, down 1.5% from CNY 192.75 million in the same period last year[20] - The company paid 62,517,952.61 CNY to employees, up from 55,062,734.29 CNY, indicating increased labor costs[25] - The cash outflow for purchasing goods and services was 176,034,123.65 CNY, compared to 160,938,109.72 CNY in the previous year, reflecting higher operational costs[25] Investments - Investment income dropped by 69.32% to CNY 100,684.93, primarily due to reduced returns from capital-protected financial products[6] - Cash outflows from investment activities decreased by 54.12% to CNY 118,006,712.24, reflecting reduced fixed asset and external investments[7] - The cash inflow from investment activities was 35,327,559.52 CNY, compared to 34,871,335.35 CNY in the previous year, showing a slight increase[25] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 49,561, with the largest shareholder holding 23.41% of the shares[8] - The company reported a total of 111,543,406 restricted shares at the end of the period, with 81,577 shares newly restricted[13] Miscellaneous - The company received government subsidies amounting to CNY 677,923.10 during the reporting period[5] - The company is focused on maintaining a stable financial position while exploring new market opportunities and product developments[16] - The company did not conduct an audit for the first quarter report[27]

Financial Performance - The company reported a net profit attributable to shareholders of -74.435 million yuan in 2021, a significant decline of 452.69% year-on-year, primarily due to substantial goodwill impairment and increased operating expenses [4]. - The company's operating revenue for 2021 was ¥958,340,608.40, representing a 2.42% increase compared to ¥935,696,717.93 in 2020 [26]. - The net profit attributable to shareholders in 2021 was -¥74,435,026.16, a decrease of 452.69% from ¥21,105,083.14 in 2020 [26]. - The net cash flow from operating activities was -¥503,828,082.07 in 2021, down 462.83% from ¥138,859,567.05 in 2020 [26]. - The total assets at the end of 2021 were ¥3,241,835,016.69, an increase of 26.41% from ¥2,564,439,469.59 at the end of 2020 [26]. - The company reported a basic earnings per share of -¥0.15 in 2021, a decline of 400.00% from ¥0.05 in 2020 [26]. - The total non-operating income for 2021 was ¥14,386,727.25, significantly lower than ¥57,189,568.40 in 2020 [32]. - The company experienced a quarterly revenue of ¥346,494,492.61 in Q4 2021, which was the highest among the four quarters [29]. - The net profit attributable to shareholders in Q1 2021 was ¥15,347,795.32, but turned negative in subsequent quarters, culminating in -¥78,567,185.46 in Q4 [29]. - The company's total liabilities increased, leading to a decrease in net assets attributable to shareholders by 4.70% to ¥1,612,804,238.79 at the end of 2021 [26]. - The company has indicated uncertainty regarding its ability to continue as a going concern due to negative net profits in recent years [26]. Market Position and Competition - The company faces risks from intensified market competition, particularly from international firms like Thermo Fisher and Shimadzu, which may lead to reduced market share and lower gross margins [7]. - The company plans to continue enhancing its industry position and business competitiveness to improve operational performance despite the challenges faced [4]. - The company has formed stable partnerships with numerous well-known enterprises, enhancing its market competitiveness through collaborative synergies [44]. - The environmental protection industry is experiencing rapid growth due to increased government investment and policy support, positioning the company favorably within this sector [39]. - The company is a leader in the domestic analytical instrument industry, focusing on analysis detection, environmental monitoring, ecological governance, and related services [59]. Research and Development - The company is committed to advancing its research and development capabilities to maintain a competitive edge in the analytical instrument market [60]. - The company has established a rigorous R&D process divided into four stages: concept initiation, planned development, prototype validation, and product launch [64]. - The company has invested 30 million RMB in R&D for new technologies in environmental monitoring and analysis [72]. - The company is investing 100 million yuan in R&D for the next fiscal year to enhance product capabilities and technological advancements [75]. - The company has outlined a strategic goal to achieve a 30% increase in net profit for the next fiscal year [76]. - The company has successfully obtained 163 patents, including 45 invention patents and 118 utility model patents, enhancing its competitive edge in the market [77]. - The company has developed multiple software applications for its products, including the "VOCs Online Monitoring System Application Software V4.0," which was launched on October 15, 2017 [88]. - The company is focusing on research and development of innovative technologies to improve testing accuracy and efficiency, which is anticipated to strengthen its competitive position [83]. Product Development and Innovation - New product launches include the EDX3500 and EDX8800 spectrometers, which are expected to contribute an additional 10% to the annual revenue [73]. - The introduction of a new line of food safety testing instruments is set to launch in Q2 2022, targeting a market size of 500 million yuan [75]. - The company has introduced a new automatic monitoring system for water quality, expected to capture a significant share of the environmental monitoring market [81]. - The company is actively developing new technologies, with 15 patents granted in 2021, including innovations in X-ray fluorescence and gas chromatography [75]. - The company has developed a dual optical path colorimetric technology that significantly improves measurement stability by eliminating deviations caused by changes in light source intensity or background [98]. - The introduction of a non-contact optical quantitative sensor has reduced the cost of online water quality analyzers while ensuring sample accuracy [98]. - The company has implemented high-speed mass spectrometry data acquisition technology, significantly improving the performance metrics of mass spectrometers [98]. Strategic Acquisitions and Partnerships - The company is exploring potential acquisitions to enhance its technology portfolio and expand its capabilities in analytical instrumentation [72]. - A strategic acquisition of a smaller competitor is anticipated to be completed by Q3 2022, expected to increase market share by 5% [74]. - The company has completed the acquisition of 100% equity in Suzhou Wending Environmental Technology Co., Ltd. for 135 million, integrating it as a wholly-owned subsidiary [165]. - The company is focused on expanding its market presence through strategic acquisitions and establishing new subsidiaries in the environmental technology sector [164]. - The company has established a new subsidiary in Hunan with an investment of 10 million yuan to develop medical devices and related technologies [172]. Financial Management and Investment - The company has a procurement model that includes long-term partnerships with several well-known suppliers for core components and key raw materials, ensuring quality and cost-effectiveness [65]. - The cash inflow from financing activities increased by 63.50% to ¥862,032,594.39, mainly due to increased bank loans [126]. - The company reported a significant increase in financial expenses by 95.31% year-over-year, totaling approximately ¥22.54 million, attributed to increased bank loans for project financing [119]. - The company has a cash balance of CNY 21.90 million, which is restricted due to performance guarantees and bank account freezes [136]. - The company has pledged 99% of its equity in a subsidiary as collateral for a bank loan amounting to CNY 99 million [136]. Operational Challenges and Risks - The company has indicated uncertainty regarding its ability to continue as a going concern due to negative net profits in recent years [26]. - The company faces risks from market competition, particularly from international giants and low-end product homogenization, which affects overall industry profitability [181]. - There is a risk of talent and technology loss, which could negatively impact production and operations if key personnel leave [182]. - The company aims to minimize the impact of goodwill from acquisitions on future performance by optimizing resource allocation and maintaining competitive advantages across business segments [183]. Corporate Governance - The company held five shareholder meetings during the reporting period, all conducted in compliance with regulations, ensuring the legality and effectiveness of voting results [188]. - The board of directors consists of 9 members, including 3 independent directors, meeting the requirements of relevant laws and regulations [190]. - The company has established a transparent performance evaluation and incentive mechanism for senior management, ensuring compliance with legal standards [192]. - The company maintains an independent business operation, with no competition or unfair related transactions with the controlling shareholder [196]. - The company has a complete governance structure that complies with the requirements of the China Securities Regulatory Commission and the Shenzhen Stock Exchange [195].